323 related articles for article (PubMed ID: 23175232)
1. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.
Oikawa T; Kamiya A; Zeniya M; Chikada H; Hyuck AD; Yamazaki Y; Wauthier E; Tajiri H; Miller LD; Wang XW; Reid LM; Nakauchi H
Hepatology; 2013 Apr; 57(4):1469-83. PubMed ID: 23175232
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Yong KJ; Gao C; Lim JS; Yan B; Yang H; Dimitrov T; Kawasaki A; Ong CW; Wong KF; Lee S; Ravikumar S; Srivastava S; Tian X; Poon RT; Fan ST; Luk JM; Dan YY; Salto-Tellez M; Chai L; Tenen DG
N Engl J Med; 2013 Jun; 368(24):2266-76. PubMed ID: 23758232
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
4. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O
Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380
[TBL] [Abstract][Full Text] [Related]
5. Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells.
Oikawa T; Kamiya A; Kakinuma S; Zeniya M; Nishinakamura R; Tajiri H; Nakauchi H
Gastroenterology; 2009 Mar; 136(3):1000-11. PubMed ID: 19185577
[TBL] [Abstract][Full Text] [Related]
6. SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.
Deng G; Zhu L; Huang F; Nie W; Huang W; Xu H; Zheng S; Yi Z; Wan T
Oncotarget; 2015 Sep; 6(29):27416-26. PubMed ID: 26317546
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression.
Tian Q; Xiao Y; Wu Y; Liu Y; Song Z; Gao W; Zhang J; Yang J; Zhang Y; Guo T; Dai F; Sun Z
Int J Mol Med; 2016 Nov; 38(5):1587-1595. PubMed ID: 28026002
[TBL] [Abstract][Full Text] [Related]
8. [Expression of sal-like 4 in primary hepatocellular carcinoma and its association with epithelial-mesenchymal transition].
Xu J; Wang J; Hu Y; Wang XX; Cheng LL; Yu HY
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):500-505. PubMed ID: 27784427
[No Abstract] [Full Text] [Related]
9. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
10. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
[TBL] [Abstract][Full Text] [Related]
11. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
12. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan.
Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH
Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199
[No Abstract] [Full Text] [Related]
14. Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells.
Oikawa T; Wauthier E; Dinh TA; Selitsky SR; Reyna-Neyra A; Carpino G; Levine R; Cardinale V; Klimstra D; Gaudio E; Alvaro D; Carrasco N; Sethupathy P; Reid LM
Nat Commun; 2015 Oct; 6():8070. PubMed ID: 26437858
[TBL] [Abstract][Full Text] [Related]
15. Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma.
Tanaka Y; Aishima S; Kohashi K; Okumura Y; Wang H; Hida T; Kotoh K; Shirabe K; Maehara Y; Takayanagi R; Oda Y
Histopathology; 2016 Apr; 68(5):693-701. PubMed ID: 26267070
[TBL] [Abstract][Full Text] [Related]
16. Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.
Han SX; Wang JL; Guo XJ; He CC; Ying X; Ma JL; Zhang YY; Zhao Q; Zhu Q
J Immunol Res; 2014; 2014():262385. PubMed ID: 24860834
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
18. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
19. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
